REGENXBIO
RGNX
A$12.91
Share price
-4.32%
Change (1 day)
-41.17%
Change (1 year)
Categories
Market capitalization of REGENXBIO (RGNX)
Market cap: A$0.65 Billion
As of July 2025 REGENXBIO has a market cap of A$0.65 Billion. This makes REGENXBIO the world's 7403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of REGENXBIO from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$0.65 B | 10.18% |
| 2024 | A$0.59 B | -49.08% |
| 2023 | A$1.15 B | -19.67% |
| 2022 | A$1.44 B | -25.2% |
| 2021 | A$1.92 B | -12.74% |
| 2020 | A$2.21 B | 2.13% |
| 2019 | A$2.16 B | 0.64% |
| 2018 | A$2.15 B | 62.15% |
| 2017 | A$1.32 B | 94.69% |
| 2016 | A$0.68 B | 13.63% |
| 2015 | A$0.59 B |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of REGENXBIO was reported to be:
A$0.64 Billion
A$0.65 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$1.44 B | 122.01% | 🇺🇸 USA |